Notably, it was found that PD-L1 overexpression caused an obvious suppression of tumor-infiltrating CD8+ T-cells, and there was no significant change of the percentage of CD8+ T-cells between diverse treatments in the PD-L1 overexpressing tumor (Fig 4 E and F). This evidence concerns the gene CD274 and neoplasm.